SEHK:1952Biotechs
A Look At Everest Medicines (SEHK:1952) Valuation After Recent Share Price Pullback
Everest Medicines share performance context
Everest Medicines (SEHK:1952) has drawn attention after a sharp share price pullback, with the stock showing a 4.0% decline over the past day and a 32.6% decline over the past 3 months.
See our latest analysis for Everest Medicines.
The recent 4.0% one day share price decline and 15.9% 30 day share price return, combined with a 47.3% 1 year total shareholder return loss, point to fading momentum despite a very large 3 year total shareholder return...